Neuro-Oncology: The Podcast

99 Folgen

1. Long-term outcomes of pediatric patients with optic pathway glioma

   Vom: 4.5.2024
2. NF1 mutation and neuronal hyperexcitability

   Vom: 12.4.2024
3. Postoperative cerebellar mutism

   Vom: 5.4.2024
4. Cell cycle checkpoints and alkylating agents

   Vom: 22.3.2024
5. Liquid biopsy in CNS lymphoma

   Vom: 15.3.2024
6. Immunotherapy for glioblastoma, lessons learned

   Vom: 8.3.2024
7. TERTp mutation clonality in glioma

   Vom: 27.2.2024
8. Liquid biopsy in H3K27M glioma

   Vom: 9.2.2024
9. Glioma genetic profiles and electrophysiologic hyperexcitability

   Vom: 26.1.2024
10. Epidemiology of glioma in Belgium

    Vom: 12.1.2024
11. The Biology of H3K27M Mutant Gliomas

    Vom: 23.12.2023
12. 3D tumor volume assessment in PCNSL

    Vom: 1.12.2023
13. Brain-tumor related epilepsy; a SNO consensus review

    Vom: 17.11.2023
14. Vorasidenib and grading of IDH mutant astrocytoma

    Vom: 27.10.2023
15. Insulin feedback and PI3K inhibition in GBM

    Vom: 6.10.2023
16. SOX10 indel mutations in schwannomas

    Vom: 22.9.2023
17. Dendritic cell vaccines in gliomas

    Vom: 8.9.2023
18. Intrathecal trastuzumab for leptomeningeal metastases

    Vom: 11.8.2023
19. Short term topiramate for radiation induced cytotoxic edema

    Vom: 21.7.2023
20. Venous thromboembolism in gliomas

    Vom: 8.7.2023